Cargando…
Platelet aggregation inhibitors in primary and secondary prevention of ischemic stroke
BACKGROUND: The ischaemic stroke (IS) is one of the most frequent cause of death in Germany. Besides of non-drug many drug-based interventions are used in primary or secondary prevention of IS, among them the thrombocyte aggregation inhibitors (TAI). OBJECTIVES: The evaluation addresses the question...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
German Medical Science
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011360/ https://www.ncbi.nlm.nih.gov/pubmed/21289960 |